11/12/2024 | Press release | Distributed by Public on 11/12/2024 15:42
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | | | | | $ | | | ||
Underwriting discounts and commissions(1)
|
| | | $ | | | | | $ | | | ||
Proceeds, before expenses, to Grid Dynamics
|
| | | $ | | | | | $ | | | |
| | |
Page
|
| |||
Prospectus Supplement | | | | | | | |
About This Prospectus Supplement
|
| | | | S-i | | |
Prospectus Supplement Summary
|
| | | | S-1 | | |
Risk Factors
|
| | | | S-13 | | |
Forward-Looking Statements
|
| | | | S-15 | | |
Use of Proceeds
|
| | | | S-17 | | |
Dividend Policy
|
| | | | S-18 | | |
Capitalization
|
| | | | S-19 | | |
Dilution
|
| | | | S-20 | | |
Material U.S. Federal Income Tax Consequences for Non-U.S. Holders of Common Stock
|
| | | | S-22 | | |
Underwriting
|
| | | | S-26 | | |
Selling Restrictions
|
| | | | S-30 | | |
Enforceability of Civil Liabilities
|
| | | | S-37 | | |
Legal Matters
|
| | | | S-37 | | |
Experts
|
| | | | S-37 | | |
Where You Can Find Additional Information
|
| | | | S-37 | | |
Incorporation by Reference
|
| | | | S-38 | | |
| | |
Page
|
| |||
Prospectus | | | | | | | |
About This Prospectus
|
| | | | 1 | | |
Where You Can Find More Information
|
| | | | 2 | | |
Incorporation By Reference
|
| | | | 2 | | |
The Company
|
| | | | 3 | | |
Risk Factors
|
| | | | 4 | | |
Forward-Looking Statements
|
| | | | 5 | | |
Use of Proceeds
|
| | | | 6 | | |
Description of Common Stock
|
| | | | 7 | | |
Plan of Distribution
|
| | | | 10 | | |
Legal Matters
|
| | | | 11 | | |
Experts
|
| | | | 11 | | |
| | |
Year ended December 31,
|
| |||||||||||||||||||||||||||||||||
| | |
2023
|
| |
2022
|
| |
2021
|
| |||||||||||||||||||||||||||
| | | | | | | | |
% of revenue
|
| | | | | | | |
% of revenue
|
| | | | | | | |
% of revenue
|
| |||||||||
| | |
(in thousands, except percentages)
|
| |||||||||||||||||||||||||||||||||
Retail
|
| | | $ | 102,551 | | | | | | 32.8% | | | | | $ | 99,681 | | | | | | 32.1% | | | | | $ | 61,717 | | | | | | 29.2% | | |
Tech, Media and Telecom
|
| | | | 98,830 | | | | | | 31.6% | | | | | | 98,334 | | | | | | 31.7% | | | | | | 67,689 | | | | | | 32.0% | | |
CPG/Manufacturing
|
| | | | 42,861 | | | | | | 13.7% | | | | | | 61,216 | | | | | | 19.7% | | | | | | 43,461 | | | | | | 20.6% | | |
Finance
|
| | | | 28,842 | | | | | | 9.2% | | | | | | 21,893 | | | | | | 7.1% | | | | | | 17,515 | | | | | | 8.3% | | |
Other
|
| | | | 39,826 | | | | | | 12.7% | | | | | | 29,358 | | | | | | 9.4% | | | | | | 20,898 | | | | | | 9.9% | | |
Total
|
| | | $ | 312,910 | | | | | | 100.0% | | | | | $ | 310,482 | | | | | | 100.0% | | | | | $ | 211,280 | | | | | | 100.0% | | |
| | |
Three Months Ended September 30,
|
| |
Nine Months Ended September 30,
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
2024
|
| |
2023
|
| |
2024
|
| |
2023
|
| ||||||||||||||||||||||||||||||||||||
| | |
(in thousands, except percentages)
|
| |||||||||||||||||||||||||||||||||||||||||||||
Retail
|
| | | $ | 29,825 | | | | | | 34.1% | | | | | $ | 26,544 | | | | | | 34.3% | | | | | $ | 81,233 | | | | | | 32.5% | | | | | $ | 77,972 | | | | | | 33.2% | | |
Technology, Media and Telecom
|
| | | | 24,188 | | | | | | 27.7% | | | | | | 23,732 | | | | | | 30.7% | | | | | | 71,449 | | | | | | 28.5% | | | | | | 74,639 | | | | | | 31.8% | | |
Finance
|
| | | | 14,158 | | | | | | 16.2% | | | | | | 7,299 | | | | | | 9.4% | | | | | | 36,967 | | | | | | 14.8% | | | | | | 20,562 | | | | | | 8.8% | | |
CPG/Manufacturing
|
| | | | 9,807 | | | | | | 11.2% | | | | | | 9,668 | | | | | | 12.5% | | | | | | 29,209 | | | | | | 11.7% | | | | | | 33,186 | | | | | | 14.1% | | |
Healthcare and Pharma
|
| | | | 2,510 | | | | | | 2.9% | | | | | | 3,434 | | | | | | 4.4% | | | | | | 8,677 | | | | | | 3.5% | | | | | | 10,292 | | | | | | 4.4% | | |
Other
|
| | | | 6,947 | | | | | | 7.9% | | | | | | 6,742 | | | | | | 8.7% | | | | | | 22,754 | | | | | | 9.0% | | | | | | 18,190 | | | | | | 7.7% | | |
Total
|
| | | $ | 87,435 | | | | | | 100.0% | | | | | $ | 77,419 | | | | | | 100.0% | | | | | $ | 250,289 | | | | | | 100.0% | | | | | $ | 234,841 | | | | | | 100.0% | | |
| | |
Year Ended December 31,
|
| |
Three Months Ended
September 30, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||||||||||||||
| | |
2023
|
| |
2022
|
| |
2021
|
| |
2024
|
| |
2023
|
| |
2024
|
| |
2023
|
| ||||||||||||||||||
| | |
(in thousands, except per share data)
|
| | | | |||||||||||||||||||||||||||||||||
Statement of Operations Data | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total revenue
|
| | | $ | 312,910 | | | | | $ | 310,482 | | | | | $ | 211,280 | | | | | $ | 87,435 | | | | | $ | 77,419 | | | | | $ | 250,289 | | | |
$234,841
|
|
Income/(loss) from operations
|
| | | $ | (5,580) | | | | | $ | (21,008) | | | | | $ | 50 | | | | | $ | 2,136 | | | | | $ | 143 | | | | | $ | (3,366) | | | |
$(4,515)
|
|
Net income/(loss)
|
| | | $ | (1,765) | | | | | $ | (29,214) | | | | | $ | (7,700) | | | | | $ | 4,282 | | | | | $ | 676 | | | | | $ | (483) | | | |
$(4,667)
|
|
Comprehensive income/(loss)
|
| | | $ | 357 | | | | | $ | (29,936) | | | | | $ | (7,822) | | | | | $ | 4,496 | | | | | $ | 115 | | | | | $ | (574) | | | |
$(3,330)
|
|
Basic income/(loss) per share(1)
|
| | | $ | (0.02) | | | | | $ | (0.42) | | | | | $ | (0.13) | | | | | $ | 0.06 | | | | | $ | 0.01 | | | | | $ | (0.01) | | | |
$(0.06)
|
|
Diluted income/(loss) per share(1)
|
| | | $ | (0.02) | | | | | $ | (0.42) | | | | | $ | (0.13) | | | | | $ | 0.05 | | | | | $ | 0.01 | | | | | $ | (0.01) | | | |
$(0.06)
|
|
Cash Flow Data | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net cash provided by operating activities
|
| | | $ | 41,093 | | | | | $ | 31,652 | | | | | $ | 17,973 | | | | | $ | 9,213 | | | | | $ | 10,958 | | | | | $ | 23,130 | | | |
$33,537
|
|
Net cash used in investing
activities |
| | | $ | (25,950) | | | | | $ | (16,323) | | | | | $ | (35,366) | | | | | $ | 27,397 | | | | | $ | 1,840 | | | | | $ | (41,314) | | | |
$(23,423)
|
|
Net cash (used in)/provided by financing activities
|
| | | $ | (16,321) | | | | | $ | 97,758 | | | | | $ | 49,134 | | | | | $ | (5,679) | | | | | $ | 1,020 | | | | | $ | (7,768) | | | |
$(14,467)
|
|
Consolidated Balance Sheet Data
|
| |
As of September 30, 2024
|
| |||||||||
(in thousands)
|
| |
Actual
|
| |
As adjusted(1)
|
| ||||||
Cash and cash equivalents
|
| | | $ | 231,261 | | | | | $ | 324,061 | | |
Working capital
|
| | | $ | 268,761 | | | | | $ | 361,561 | | |
Total assets
|
| | | $ | 477,252 | | | | | $ | 570,052 | | |
Total liabilities
|
| | | $ | 77,005 | | | | | $ | 77,005 | | |
Total stockholders' equity
|
| | | $ | 400,247 | | | | | $ | 493,047 | | |
| | |
Three Months Ended
September 30, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2024
|
| |
2023
|
| |
2024
|
| |
2023
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
GAAP net income/(loss)
|
| | | $ | 4,282 | | | | | $ | 676 | | | | | $ | (483) | | | | | $ | (4,667) | | |
Adjusted for:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 3,424 | | | | | | 2,478 | | | | | | 9,579 | | | | | | 6,255 | | |
Provision for income taxes
|
| | | | 1,320 | | | | | | 2,626 | | | | | | 5,773 | | | | | | 8,001 | | |
Stock-based compensation
|
| | | | 7,139 | | | | | | 7,267 | | | | | | 25,969 | | | | | | 27,677 | | |
Transaction and transformation-related costs(1)
|
| | | | 1,571 | | | | | | 436 | | | | | | 2,238 | | | | | | 1,519 | | |
Geographic reorganization(2)
|
| | | | 316 | | | | | | 306 | | | | | | 1,262 | | | | | | 1,528 | | |
Restructuring costs(3)
|
| | | | 227 | | | | | | 103 | | | | | | 1,157 | | | | | | 1,086 | | |
Other (income)/expense, net(4)
|
| | | | (3,466) | | | | | | (3,159) | | | | | | (8,656) | | | | | | (7,849) | | |
Non-GAAP EBITDA
|
| | | $ | 14,813 | | | | | $ | 10,733 | | | | | $ | 36,839 | | | | | $ | 33,550 | | |
| | |
Year Ended
December 31, 2023 (in thousands) |
| |||
GAAP net loss
|
| | | $ | (1,765) | | |
Adjusted for: | | | | | | | |
Depreciation and amortization
|
| | | | 8,926 | | |
Provision for income taxes
|
| | | | 6,603 | | |
Stock-based compensation
|
| | | | 35,516 | | |
Geographic reorganization(1)
|
| | | | 1,858 | | |
Transaction and transformation-related costs(2)
|
| | | | 2,038 | | |
Restructuring(3)
|
| | | | 1,488 | | |
Other (income)/expense, net(4)
|
| | | | (10,418) | | |
Non-GAAP EBITDA
|
| | | $ | 44,246 | | |
| | |
Three Months Ended
September 30, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2024
|
| |
2023
|
| |
2024
|
| |
2023
|
| ||||||||||||
| | |
(in thousands, except per share data)
|
| |||||||||||||||||||||
GAAP net income/(loss)
|
| | | $ | 4,282 | | | | | $ | 676 | | | | | $ | (483) | | | | | $ | (4,667) | | |
Adjusted for: | | | | | | | | | | | | | | | | | | | | | | | | | |
Stock-based compensation
|
| | | | 7,139 | | | | | | 7,267 | | | | | | 25,969 | | | | | | 27,677 | | |
Transaction and transformation-related costs(1)
|
| | | | 1,571 | | | | | | 436 | | | | | | 2,238 | | | | | | 1,519 | | |
Geographic reorganization(2)
|
| | | | 316 | | | | | | 306 | | | | | | 1,262 | | | | | | 1,528 | | |
Restructuring costs(3)
|
| | | | 227 | | | | | | 103 | | | | | | 1,157 | | | | | | 1,086 | | |
Other (income)/expense, net(4)
|
| | | | (3,466) | | | | | | (3,159) | | | | | | (8,656) | | | | | | (7,849) | | |
Tax impact of non-GAAP adjustments(5)
|
| | | | (1,982) | | | | | | 232 | | | | | | (2,132) | | | | | | 86 | | |
Non-GAAP net income
|
| | | $ | 8,087 | | | | | $ | 5,861 | | | | | $ | 19,355 | | | | | $ | 19,380 | | |
Number of shares used in the GAAP diluted EPS
|
| | | | 78,837 | | | | | | 77,339 | | | | | | 76,485 | | | | | | 75,026 | | |
GAAP diluted EPS
|
| | | $ | 0.05 | | | | | $ | 0.01 | | | | | $ | (0.01) | | | | | $ | (0.06) | | |
Number of shares used in the Non-GAAP diluted EPS
|
| | | | 78,837 | | | | | | 77,339 | | | | | | 78,301 | | | | | | 77,298 | | |
Non-GAAP diluted EPS
|
| | | $ | 0.10 | | | | | $ | 0.08 | | | | | $ | 0.25 | | | | | $ | 0.25 | | |
| | |
Year Ended
December 31, 2023 (in thousands except per share data) |
| |||
GAAP net loss
|
| | | $ | (1,765) | | |
Adjusted for: | | | | | | | |
Stock-based compensation
|
| | | | 35,516 | | |
Geographic reorganization(1)
|
| | | | 1,858 | | |
Transaction and transformation-related costs(2)
|
| | | | 2,038 | | |
Restructuring(3)
|
| | | | 1,488 | | |
Other (income)/expense, net(4)
|
| | | | (10,418) | | |
Tax impact of non-GAAP adjustments(5)
|
| | | | (3,640) | | |
Non-GAAP Net Income
|
| | | $ | 25,077 | | |
Number of shares used in the Non-GAAP Diluted EPS
|
| | | | 75,193 | | |
GAAP Diluted EPS
|
| | | $ | (0.02) | | |
Number of shares used in the Non-GAAP diluted EPS
|
| | |
|
77,651
|
| |
Non-GAAP diluted EPS
|
| | | $ | 0.32 | | |
(unaudited, in thousands)
|
| |
Actual
|
| |
As Adjusted
|
| ||||||
Cash and cash equivalents
|
| | | $ | 231,261 | | | | | $ | 324,061 | | |
Stockholders' equity: | | | | | | | | | | | | | |
Preferred stock, $0.0001 par value per share; 1,000,000 shares authorized, no shares
issued or outstanding actual and as adjusted |
| | | | - | | | | | | - | | |
Common stock, $0.0001 par value per share; 110,000,000 shares authorized, 76,742,933 and 81,742,933 issued and outstanding, actual and as adjusted, respectively
|
| | | | 8 | | | | | | 9 | | |
Additional paid-in capital
|
| | | | 415,425 | | | | | $ | 508,224 | | |
Accumulated deficit
|
| | | | (16,369) | | | | | | (16,369) | | |
Accumulated other comprehensive income
|
| | | | 1,183 | | | | | | 1,183 | | |
Total stockholders' equity
|
| | | | 400,247 | | | | | $ | 493,047 | | |
Total capitalization
|
| | | $ | 400,247 | | | | | $ | 493,047 | | |
|
Assumed public offering price per share
|
| | | | | | | | | $ | 19.61 | | |
|
Net tangible book value per share as of September 30, 2024
|
| | | $ | 3.60 | | | | | | | | |
|
Increase in net tangible book value per share attributable to investors participating in the offering
|
| | | $ | 0.91 | | | | |||||
|
As adjusted net tangible book value per share, as adjusted to give effect to this
offering |
| | | | | | | | | $ | 4.51 | | |
|
Dilution in as adjusted net tangible book value per share to investors participating in this
offering |
| | | | | | | | | $ | 15.10 | | |
Underwriter
|
| |
Number of
Shares |
|
J.P. Morgan Securities LLC
|
| | | |
William Blair & Company, L.L.C.
|
| | | |
TD Securities (USA) LLC
|
| | | |
Needham & Company, LLC
|
| | | |
Total
|
| | | |
| | |
Without option to
purchase additional shares exercise |
| |
With full option to
purchase additional shares exercise |
| ||||||
Per share
|
| | | $ | | | | | $ | | | ||
Total
|
| | | $ | | | | | $ | | | |
|
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 2 | | |
|
INCORPORATION BY REFERENCE
|
| | | | 2 | | |
|
THE COMPANY
|
| | | | 3 | | |
|
RISK FACTORS
|
| | | | 4 | | |
|
FORWARD-LOOKING STATEMENTS
|
| | | | 5 | | |
|
USE OF PROCEEDS
|
| | | | 6 | | |
|
DESCRIPTION OF COMMON STOCK
|
| | | | 7 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 10 | | |
|
LEGAL MATTERS
|
| | | | 11 | | |
| EXPERTS | | | | | 11 | | |